PFS:无进展生存

“无进展生存期”(Progression Free Survival,简称PFS)是肿瘤学中评估治疗效果的重要指标,常缩写为PFS以方便医学记录与交流。它特指患者在疾病未出现恶化前提下的生存时间,在临床研究和治疗随访中具有关键意义。这一术语的规范使用有助于提升医学资料的专业性与沟通效率。

Progression Free Survival具体释义

  • 英文缩写:PFS
  • 英语全称:Progression Free Survival
  • 中文意思:无进展生存
  • 中文拼音:wú jìn zhǎn shēng cún
  • 相关领域pfs 肿瘤学

Progression Free Survival的英文发音

例句

  1. Influencing Factors of Progression Free Survival(PFS) in Late Course Conformal Radiotherapy for ⅲ Stage Non-small Cell Lung Cancer
  2. 后程适形放疗治疗Ⅲ期非小细胞肺癌无进展生存(PFS)期影响因素分析
  3. In this trial, the overall median progression free survival ( PFS ) was9.2 months with pazopanib and4.2 months with placebo.
  4. 在这个试验中,整体无进展生存(PFS)期(PFS)为9.2和4.2个月,帕唑帕尼与安慰剂个月。
  5. The 1 - and 2-year local progression free survival ( LPFS ) rates were both 88.8 %.
  6. 1年、2年的无局部进展生存率(LPFS)均为88.8%。
  7. The secondary endpoints included progression free survival ( PFS ), local control rate and acute toxicity.
  8. 次要终点包括总生存(OS)、局部控制率及药物急性毒性。
  9. Follow up studies found that the expression of sPD-L1 was negatively correlated with clinical response. Lung cancer group with high sPD-L1 expression exhibited longer progression free survival ( PFS ) and higher 1-year survival rate, indicating better prognosis.
  10. 临床随访研究发现,肺癌患者血清sPD-L1表达水平和临床疗效呈负相关,在预后方面低表达sPD-L1组肺癌患者无进展生存(PFS)期更长、1年生存率更高,预后更好。